IP Library Granted Patent US 11,116,813
Granted Patent B2
US 11,116,813 · App. 16/495,332 · Granted Sep 14, 2021

Antimicrobial garlic compositions

Inventors: Li Vern Peng (Kuala Lumpur, MY); King Ting Lim (Kuala Lumpur, MY); Patricia De Costa (Kuala Lumpur, MY)
Assignee: MOOTRAL SA
A61K36/8962A23K20/142A61K31/10A61K31/198A61K33/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,116,813
App. No.
16/495,332
Granted
Sep 14, 2021
Kind
B2
Abstract

A composition of a first garlic extract and a second garlic extract that is different to the first garlic extract. The composition is useful as an antimicrobial, such as in pharmaceutical compositions including the first garlic extract and the second garlic extract. The invention further includes methods for making said compositions and pharmaceutical compositions.

Claims (26)

1. A therapeutic or non-therapeutic method for inhibiting the growth of and/or reducing the number of one or more microbes, the method comprising:

contacting the microbes with a composition comprising a first garlic extract and a second garlic extract different from the first garlic extract, wherein the first garlic extract is an aged garlic extract, and the second garlic extract is a non-aged garlic extract, wherein the first garlic extract comprises equal to or greater than 0.5% (w/w) polyphenol and the second garlic extract comprises equal to or greater than 0.5% (w/w) allicin.

2. A method according to claim 1 , wherein the microbe is selected from one or more of Candida albicans, Candida glabrata, Aspergillus fumigatus, Clostridium perfringens, Salmonella Typhimurium, Listeria monocytogenes, Vibrio parahaemolyticus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Bacillus cereus, Enterococcus faecalis, Campylobacter jejuni, Staphylococcus aureus , Methicillin-resistant Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes.

3. The method according to claim 1 , wherein the composition comprises an animal feed or a feed additive.

4. The method according to claim 1 , wherein the aged garlic extract is a black garlic extract, caramelised garlic extract, and/or fermented garlic extract.

5. The method according to claim 1 , wherein the non-aged garlic extract comprises deodourised garlic extract and/or deodourised garlic powder extract.

6. The method according to claim 1 , wherein the non-aged garlic extract comprises at least 3 wt % allicin.

7. The method according to claim 1 , wherein the aged garlic extract comprises at least 5 wt % polyphenol.

8. The method according to claim 1 , wherein the weight ratio of the first garlic extract to the second garlic extract ranges from 1:2000 to 100:1.

9. The method according to claim 1 , wherein the first garlic extract is a black garlic extract and the second garlic extract is a deodourised garlic extract, and the weight ratio of the first to the second garlic extract is 16:1 to 1:16.

10. The method according to claim 1 , wherein the composition comprises alliin, γ-glutamylcysteine, S-allyl-L-cysteine, or any combination of two or more thereof.

11. The method according to claim 1 , wherein the composition comprises:

equal to or greater than 1.5% (w/w) total thiosulfinates; and/or

equal to or greater than 3.2% (w/w) alliin; and/or

equal to or greater than 3.0% (w/w) γ-glutamylcysteine; and/or

equal to or greater than 0.6% (w/w) total sulfur; and/or

equal to or greater than 0.15% (w/w) S-allyl-L-cysteine.

12. The method according to claim 1 , wherein the composition is a foodstuff, a food supplement, a beverage, a beverage supplement, a dietary supplement, a health supplement, a meal replacement product, a food additive, an animal feed, or a feed additive.

13. The method according to claim 1 , wherein the composition is administered to a subject for treating or preventing a microbial infection in the subject.

14. The therapeutic method according to claim 13 , wherein the microbe is selected from one or more of bacteria and fungi.

15. A method according to claim 14 , wherein the microbe is selected from one or more of Candida albicans, Candida glabrata, Aspergillus fumigatus, Clostridium perfringens, Salmonella typhimurium, Listeria monocytogenes, Vibrio parahaemolyticus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Bacillus cereus, Enterococcus faecalis, Campylobacter jejuni, Staphylococcus aureus, Methicillin -resistant Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes.

16. The method according to claim 13 , wherein the composition comprises an animal feed or a feed additive.

17. The method according to claim 1 , wherein the aged garlic extract is formed from garlic stored in water or alcohol before extraction.

18. The method according to claim 1 , wherein each of the first garlic extract and the second garlic extract is an aqueous or non-aqueous solvent extract.

19. The method according to claim 9 , wherein the first garlic extract in combination with the second garlic extract provides a synergistic antimicrobial effect.

20. The method according to claim 19 , wherein the synergistic antimicrobial effect is greater than a sum of an individual garlic extract antimicrobial effect of the first garlic extract and the second garlic extract.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 17, 2024
From: MOOTRAL SA
To: MOOTRAL INNOVATIONS LIMITED
Reel/Frame 068605/0679 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2019
From: PENG, LI VERN; LIM, KING TING; DE COSTA, PATRICIA
To: MOOTRAL SA
Reel/Frame 050613/0176 →
Priority Claims (1)
MY PI2017701113 · Mar 30, 2017 · national
Continuity (1)
Related Publication 20200016227A1 · Jan 16, 2020